Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.
Follow ISRG
Intuitive Surgical, Inc. (ISRG) Price to free cash flow
As of 16 October 2026, Intuitive Surgical, Inc. (ISRG) trades at a price to free cash flow of 46.2×. Over the past ten years it has ranged from 23.3× (January 2017) to 418× (September 2024); the current reading is higher than 29% of that period. That is above the Medical Instruments & Supplies industry median of 25.2× and above the Healthcare sector median of 20.2×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 81.2× | (42.93%) |
| FY2024 | 142× | (8.30%) |
| FY2023 | 155× | 57.29% |
| FY2022 | 98.6× | 34.83% |
| FY2021 | 73.1× | (12.69%) |
| FY2020 | 83.7× | 43.95% |
| FY2019 | 58.2× | 4.94% |
| FY2018 | 55.4× | 26.08% |
| FY2017 | 44.0× | 84.81% |
| FY2016 | 23.8× | (14.84%) |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 43.1× | (24.15%) |
| Mar 2026 | 56.8× | (30.01%) |
| Dec 2025 | 81.2× | 15.58% |
| Sep 2025 | 70.2× | (28.12%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| SOLV Solventum Corporation compare | n/m |
| MDLN Medline Inc. compare | 13.4× |
| BAX Baxter International Inc. compare | 16.1× |
| BDX Becton, Dickinson and Company compare | 16.5× |
| ALC Alcon compare | 20.2× |
| RMD ResMed Inc. compare | 21.4× |
| ISRG Intuitive Surgical, Inc. | 46.2× |
| WST West Pharmaceutical Services, Inc. compare | 62.6× |
| RGEN Repligen Corporation compare | 162× |
| Medical Instruments & Supplies industry median | 25.2× |
| Healthcare sector median | 20.2× |
| Market median | 14.2× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement